In primary TTLshort ALL cells, both inhibitors showed no increase in cell death, Annexin-V positivity, caspase 3 cleavage or LC3 conversion at different time points, indicating no induction of overall cell death, apoptosis or autophagy (FIGURE 3E, F, G, H). Here, MAP1LC3A is linked to acute lymphoblastic leukemia.